The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fritsche, G.
Right arrow Articles by Weiss, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fritsche, G.
Right arrow Articles by Weiss, G.
The Journal of Immunology, 2003, 171: 1994-1998.
Copyright © 2003 by The American Association of Immunologists

Nramp1 Functionality Increases Inducible Nitric Oxide Synthase Transcription Via Stimulation of IFN Regulatory Factor 1 Expression

Gernot Fritsche*, Margit Dlaska*, Howard Barton{dagger}, Igor Theurl*, Katja Garimorth* and Günter Weiss1,*

* Department of Internal Medicine, University Hospital of Innsbruck, Innsbruck, Austria; and {dagger} Division of Biochemistry and Molecular Biology, University of Southampton, Southampton, United Kingdom

Natural-resistance associated macrophage protein 1 (Nramp1) encodes a transmembrane phagolysosomal protein exerting resistance toward infections with intracellular pathogens by a mechanism not fully elucidated so far. We used the murine macrophage cell line RAW264.7, stably transfected with functional (RAW-37) or nonfunctional (RAW-21) Nramp1, to study for differences in the expression of NO, a central antimicrobial effector molecule of macrophages. Following stimulation with IFN-{gamma} and LPS, Nramp1-expressing cells exhibit higher enzymatic activity of inducible NO synthase (iNOS) and increased cytoplasmic iNOS mRNA levels than RAW-21 cells. Time-course experiments showed that iNOS-mRNA levels remain increased in RAW-37 cells after prolonged cytokine stimulation while they decrease in RAW-21 cells. Reporter gene assays with iNOS-promoter luciferase constructs demonstrated an increased and prolonged promoter activity in Nramp1-resistant vs susceptible cells. This was paralleled by increased IFN regulatory factor 1 (IRF-1) expression and binding affinity to the iNOS promoter in RAW-37 cells, which may be related to enhanced STAT-1 binding affinity in these cells. A point mutation within the IRF-1 binding site of the iNOS promoter abolished the differences in iNOS transcription between RAW-21 and RAW-37 cells. Cells carrying functional Nramp1 express increased amounts of NO, which may be related to STAT-1-mediated stimulation of IRF-1 expression with subsequent prolonged activation of iNOS transcription. Enhanced NO expression may partly underlie the protection against infection with intracellular pathogens by Nramp1 functionality.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
M. A. Gomez, S. Li, M. L. Tremblay, and M. Olivier
NRAMP-1 Expression Modulates Protein-tyrosine Phosphatase Activity in Macrophages: IMPACT ON HOST CELL SIGNALING AND FUNCTIONS
J. Biol. Chem., December 14, 2007; 282(50): 36190 - 36198.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
H. K. Bayele, C. Peyssonnaux, A. Giatromanolaki, W. W. Arrais-Silva, H. S. Mohamed, H. Collins, S. Giorgio, M. Koukourakis, R. S. Johnson, J. M. Blackwell, et al.
HIF-1 regulates heritable variation and allele expression phenotypes of the macrophage immune response gene SLC11A1 from a Z-DNA forming microsatellite
Blood, October 15, 2007; 110(8): 3039 - 3048.
[Abstract] [Full Text] [PDF]

Home page
 Innate ImmunityHome page
N. Koide, Mya Mya Mu, F. Hassan, S. Islam, G. Tumurkhuu, J. Dagvadorj, Y. Naiki, I. Mori, T. Yoshida, and T. Yokochi
Lipopolysaccharide enhances interferon-{gamma}-induced nitric oxide (NO) production in murine vascular endothelial cells via augmentation of interferon regulatory factor-1 activation
Innate Immunity, June 1, 2007; 13(3): 167 - 175.
[Abstract] [PDF]

Home page
 Vet PatholHome page
A. L. Pereira-Suarez, C. Estrada-Chavez, C. Arriaga-Diaz, P. Espinosa-Cueto, and R. Mancilla
Coexpression of NRAMP1, iNOS, and Nitrotyrosine in Bovine Tuberculosis.
Vet. Pathol., September 1, 2006; 43(5): 709 - 717.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
R. Appelberg
Macrophage nutriprive antimicrobial mechanisms
J. Leukoc. Biol., June 1, 2006; 79(6): 1117 - 1128.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. M. Wolf, D. Wolf, H. Rumpold, S. Ludwiczek, B. Enrich, G. Gastl, G. Weiss, and H. Tilg
The kinase inhibitor imatinib mesylate inhibits TNF-{alpha} production in vitro and prevents TNF-dependent acute hepatic inflammation
PNAS, September 20, 2005; 102(38): 13622 - 13627.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
J. K. White, P. Mastroeni, J.-F. Popoff, C. A. W. Evans, and J. M. Blackwell
Slc11a1-mediated resistance to Salmonella enterica serovar Typhimurium and Leishmania donovani infections does not require functional inducible nitric oxide synthase or phagocyte oxidase activity
J. Leukoc. Biol., March 1, 2005; 77(3): 311 - 320.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.